LNC
70
-2
COP
44
-3
HBAN
82
2
MCD
46
4
NEM
69
-2
PG
43
2
CMI
73
-2
CSX
50
2
PM
56
2
KMB
33
2
GRMN
40
3
O
35
4
DHI
40
3
FIS
73
11
FITB
72
2
KO
44
2
EXPD
48
-2
ES
50
3
MSI
47
-2
ADM
47
2
LNC
70
-2
COP
44
-3
HBAN
82
2
MCD
46
4
NEM
69
-2
PG
43
2
CMI
73
-2
CSX
50
2
PM
56
2
KMB
33
2
GRMN
40
3
O
35
4
DHI
40
3
FIS
73
11
FITB
72
2
KO
44
2
EXPD
48
-2
ES
50
3
MSI
47
-2
ADM
47
2
Financhill
Back

MaxCyte, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Sell
50

MXCT
MaxCyte, Inc.

Last Price:
$1.60
Seasonality Move:
14.91%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Sell
50
MaxCyte, Inc. (MXCT) is a Sell

Is MaxCyte, Inc. a Buy, Sell or Hold?

  • The current MaxCyte, Inc. [MXCT] share price is $1.60. The Score for MXCT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • MXCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MXCT Stock Price Chart

What is MaxCyte, Inc.'s stock price today?

  • The MaxCyte, Inc. share price today is $1.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MXCT is experiencing buying pressure, which is a positive indicator for future bullish movement.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

MXCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 52.42 Buy
Chaikin Money Flow: 179649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.51 - 1.67) Buy
Bollinger Bands (100): (1.41 - 1.69) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

MXCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.53 Buy
20-day SMA: 1.56 Buy
50-day SMA: 1.59 Buy
200-day SMA: 2 Sell
8-day EMA: 1.56 Buy
20-day EMA: 1.56 Buy
50-day EMA: 1.44 Buy
200-day EMA: 0.72 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

MaxCyte, Inc. Earnings Growth & MXCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.03 per share, and an increase next year of $0.12 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

MaxCyte, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):